GGrantIndex
← Search

CLINICAL TRIAL: A PHASE 2, OPEN-LABEL, SWITCH-OVER, DOSE-ESCALATION STUDY OF THE

$4,016M01FY2008RRNIH

Baylor College Of Medicine, Houston TX

Investigators

Linked publications & trials

View original record on NIH RePORTER →